Paramount Skydance boasts a premier portfolio of global media IP trading at a deep statistical discount, but a rapidly decaying linear TV core, rampant insider selling, and a staggering $79 billion debt load from the impending WBD merger render the equity toxic.
Sell-rated reports Includes Sell, Strong Sell, and Avoid-rated reports — all stocks our analysis flags as best avoided.
248 tickers rated SellUSA Compression is a highly efficient, cash-generating tollbooth for the US natural gas boom, but its staggering $3.0 billion debt load and historically peak valuation multiples completely erase the margin of safety, rendering the 8% dividend an inadequate reward for the underlying balance sheet risk.
DuPont has successfully transformed into a high-margin, cash-rich water and healthcare technology pure-play, but its premium valuation multiple and perpetual, multi-billion-dollar PFAS litigation overhang make the stock too dangerous to hold at current elevated prices.
U-Haul holds a dominant, asset-rich monopoly in DIY moving and self-storage, but extreme near-term margin compression from fleet depreciation and soft used-truck pricing forces a mechanical sell rating despite massive underlying real estate value.
Ichor is an indispensable, highly integrated fluid delivery subsystem provider riding the AI semiconductor wave, but its extreme valuation multiples, severe customer concentration, and ongoing margin execution struggles make it excessively risky at current prices.
Humana commands exceptional secular demographic tailwinds through its CenterWell integration, but devastating Medicare Advantage margin compression and a ≈40x forward P/E multiple render the stock uninvestable until the 2027 turnaround materializes.
An impenetrable, dividend-gushing infrastructure monopoly perfectly positioned for the data center boom, but severely overvalued at current multiples with high leverage constraining future upside.
Skyworks pairs a globally dominant, deeply undervalued RF engineering moat with catastrophic Apple concentration risk and volatile antitrust exposure from its $22B Qorvo merger.